Abstract
This study aimed to compare the outcomes associated with valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) with the redo bioprosthetic surgical AVR (SAVR). We utilized the data of the years 2012-2016 from the US National Inpatient Sample to identify patients who were hospitalized for
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have